½ÃÀ庸°í¼­
»óǰÄÚµå
1598457

¼¼°èÀÇ Á¶Á÷ ÀýÆí ½ÃÀå : Á¦Ç°, ±â¼ú, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Tissue Sectioning Market by Product (Accessories & Consumables, Instruments, Services), Technology (Automatic, Manual, Semiautomatic), Application, End-user - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 198 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Á¶Á÷ ÀýÆí ½ÃÀåÀº 2023³â¿¡ 10¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 11¾ï 1,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 10.72%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 20¾ï 6,000¸¸ ´Þ·¯·Î µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶Á÷ ÀýÆíÀÇ ´ë»ó ¹üÀ§´Â Çö¹Ì°æ °Ë»ç¸¦ À§ÇØ »ýü Á¶Á÷À» ¾ã°Ô Àý°³ÇÏ´Â °úÁ¤À» Æ÷ÇÔÇϸç Áø´Ü°ú ¿¬±¸ ¸ðµÎ¿¡¼­ Áß¿äÇÕ´Ï´Ù. ÇüÅ¿¡ ´ëÇÑ Á¤È®ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇϱâ À§ÇØ ÇÊ¿äÇϸç ÀÇ·áÁø´Ü°ú »ý¹°ÀÇÇבּ¸¿¡ À־ ÇʼöÀûÀÎ ÅøÀÌ µÇ°í ÀÖ½À´Ï´Ù. Áß¿äÇÑ ¼ºÀå ¿äÀÎÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡ÀÌ¸ç ¼÷·ÃµÈ Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ ¼ö¿ä¸¦ ´õ¿í ÁõÆø½ÃÄÑ À¯¸ÁÇÑ ½ÃÀå ±âȸ¸¦ º¸¿© ÀÚµ¿È­ ¸¶ÀÌÅ©·ÎÅè ¹× °í±Þ ¿°»ö ±â¼ú °³¹ß¿¡ Á¾»çÇÏ´Â ±â¾÷Àº ½Å·ÚÇÒ ¼ö ÀÖ´Â °í󸮷® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÃÖÁ¾ »ç¿ëÀÚÀÇ ¿ä±¸¿¡ ºÎÀÀÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ¹Ì·¡¸¦ ÀâÀ» ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ªÀÌ ½ÃÀåÀº ÷´Ü ÀåºñÀÇ °í°¡ÀÇ ºñ¿ë°ú ¼÷·ÃµÈ ±â¼úÀÚÀÇ Çʿ伺°ú °°Àº Á¦¾à¿¡ Á÷¸éÇϰí ÀÖÀ¸¸ç, ºñ¿ë¿¡ ¹Î°¨ÇÑ Áö¿ª¿¡¼­ÀÇ µµÀÔÀÌ °úÁ¦°¡µÇ°í ÀÖ½À´Ï´Ù. ³ôÀº ÀçÇö¼ºÀ» ´Þ¼ºÇÏ´Â °ÍÀº ¿öÅ© Ç÷οìÀÇ È¿À²¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â Ãß°¡ÀûÀÎ ÇãµéÀÔ´Ï´Ù. ¿µ»ó ÇØ¼®À» À§ÇÑ AI ÅëÇÕÀ̳ª ºñ¿ë È¿À²ÀûÀÌ°í »ç¿ëÇϱ⠽¬¿î ±â±âÀÇ °³¹ß µîÀÇ ºÐ¾ß¿¡¼­ Çõ½ÅÀ» ÀÏÀ¸Å°¸é ´õ¿í ¼ºÀåÀ» ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù. °¡¿ë ½Å±Ô Àç·áÀÇ Á¶»çµµ ºñ¾àÀûÀÎ Áøº¸ÀÇ °¡´É¼ºÀ» Áö´Ï°í ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀÌ¸ç ±â¼úÀÇ Áøº¸¿¡ °ßÀεǰí ÀÖÁö¸¸ ÀçÁ¤ÀûÀÎ À庮¿¡ Á¦¾àÀ» ¹Þ°í ÀÖÀ¸¸ç Àü·«Àû Çõ½Å°ú ½ÃÀå Æ÷Áö¼Å´×ÀÇ ´ëÀÀ¿¡ µû¶ó °­·ÂÇÑ ¼ºÀå °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 10¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 11¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 20¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 10.72%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Á¶Á÷ ÀýÆí ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Á¶Á÷ ÀýÆí ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • º´¸® Á¶Á÷ °Ë»ç¿¡ ´ëÇÑ ¿Õ¼ºÇÑ ¼ö¿ä
    • ¸¸¼ºÁúȯ ¹× ¾ÏÀÇ À¯º´·ü Áõ°¡
    • Á¶Á÷¿¡ ÀÇÇÑ °è¹ß ÇÁ·Î±×·¥ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ºÒ¸®ÇÑ »óȯ ½Ã³ª¸®¿À
  • ½ÃÀå ±âȸ
    • ¸ÂÃãÇü Ä¡·áÁ¦ ¹× Áø´ÜÁ¦ÀÇ ¼ºÀå
    • ±â¼úÀûÀ¸·Î °í±Þ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • ´ÙÀýâ°ú Á¶Á÷ °ü·Ã ¹®Á¦ÀÇ °ü·Ã¼º

Porter's Five Forces: Á¶Á÷ ÀýÆí ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¹ýÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¼öÀÖ´Â ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Á¶Á÷ ÀýÆí ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Á¶Á÷ ÀýÆí ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹ÃøÇÒ ¼ö ÀÖ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾ú½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Á¶Á÷ ÀýÆí ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Á¶Á÷ ÀýÆí ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ÀýÆí ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½Ä À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Á¶Á÷ ÀýÆí ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Á¶Á÷ ÀýÆí ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : Á¶Á÷ ÀýÆí ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

Á¶Á÷ ÀýÆí ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Á¶Á÷º´¸®°Ë»ç¿¡ ´ëÇÑ °­ÇÑ ¼ö¿ä
      • ¸¸¼º ÁúȯÀ̳ª ¾Ï Áõ°¡
      • Á¶Á÷¿¡ ÀÇÇÑ °è¹ß ÇÁ·Î±×·¥ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ºÒ¸®ÇÑ »óȯ ½Ã³ª¸®¿À
    • ±âȸ
      • °³ÀÎÈ­µÈ Ä¡·á ¹× Áø´Ü ¼ºÀå
      • ±â¼úÀûÀ¸·Î °í±Þ Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • °úÁ¦
      • º¹¼öÀÇ »óó¿Í Á¶Á÷°ú °ü·ÃµÈ ¹®Á¦ÀÇ °ü·Ã¼º
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Á¶Á÷ ÀýÆí ½ÃÀå : Á¦Ç°º°

  • ¾×¼¼¼­¸®¿Í ¼Ò¸ðǰ
  • ±â±â
    • Å©¶óÀÌ¿À½ºÅÈ
    • ·ÎÅ͸® ¸¶ÀÌÅ©·ÎÅè
    • ½½¶óÀ̵ù ¸¶ÀÌÅ©·ÎÅè
    • ¿ïÆ®¶ó ¸¶ÀÌÅ©·ÎÅè
  • ¼­ºñ½º

Á¦7Àå Á¶Á÷ ÀýÆí ½ÃÀå : ±â¼úº°

  • ÀÚµ¿
  • ¼öµ¿
  • ¹ÝÀÚµ¿

Á¦8Àå Á¶Á÷ ÀýÆí ½ÃÀå : ¿ëµµº°

  • Áø´Ü
  • Á¶»ç

Á¦9Àå Á¶Á÷ ÀýÆí ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Ŭ¸®´Ð
  • Áø´Ü ½ÇÇè½Ç
  • º´¿ø
  • ¿¬±¸¼¾ÅÍ

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Á¶Á÷ ÀýÆí ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¶Á÷ ÀýÆí ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Á¶Á÷ ÀýÆí ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abcam Plc
  • AGD Biomedicals(P) Ltd.
  • Amos Scientific Pty Ltd
  • Boeckeler Instruments, Inc.
  • Covance Inc.
  • Danaher Corporation
  • Leica Biosystems Nussloch GmbH
  • LLS ROWIAK LaserLabSolutions GmbH
  • MEDITE GmbH
  • Sakura Finetek Japan, Co., Ltd.
  • SLEE medical GmbH
  • SM Scientific Instruments Pvt. Ltd.
  • Thermo Fisher Scientific Inc.
JHS 24.12.04

The Tissue Sectioning Market was valued at USD 1.01 billion in 2023, expected to reach USD 1.11 billion in 2024, and is projected to grow at a CAGR of 10.72%, to USD 2.06 billion by 2030.

The scope of tissue sectioning encompasses the process of slicing thin sections of biological tissues for microscopic examination, crucial in both diagnostics and research. Its necessity arises in pathology, molecular biology, and histology to deliver precise data on tissue architecture and cell morphology, serving as an indispensable tool in medical diagnostics and biomedical research. The application of tissue sectioning extends across various fields including hospitals, diagnostic laboratories, and academic institutes, with a primary end-use focus in cancer diagnostics, disease pathology, and drug discovery. A significant growth factor is the increasing prevalence of chronic diseases, propelling demand for proficient diagnostics. Advancements in automation and digital pathology further amplify this demand by enhancing precision and efficiency, representing promising market opportunities. Companies engaged in developing automated microtomes and advanced staining techniques can seize these prospects by catering to end-users' growing need for reliable, high-throughput solutions. However, the market faces limitations such as the high costs of advanced equipment and the requirement for skilled technicians, posing adoption challenges in cost-sensitive regions. Maintaining the quality of sections and achieving high reproducibility are additional hurdles impacting workflow efficiency. Innovating in areas like AI integration for image analysis and developing cost-effective, user-friendly equipment could unlock further growth. Research into novel materials for blades and embedding media also holds potential for breakthroughs. To capitalize on these opportunities, businesses should invest in R&D to refine automation technologies and expand their regional footprints by addressing pricing strategies pertinent to emerging economies. The market is dynamic, driven by technological advancements yet constrained by financial barriers, indicating a robust potential for growth contingent upon strategic innovations and responsive market positioning.

KEY MARKET STATISTICS
Base Year [2023] USD 1.01 billion
Estimated Year [2024] USD 1.11 billion
Forecast Year [2030] USD 2.06 billion
CAGR (%) 10.72%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Sectioning Market

The Tissue Sectioning Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Strong demand for histopathology tests
    • Growing prevalence of chronic diseases and cancers
    • Rise in awareness programs undertaken by organizations
  • Market Restraints
    • Adverse Reimbursement scenario
  • Market Opportunities
    • Growth of personalized therapeutics and diagnostics
    • Rising demand for technologically advanced products
  • Market Challenges
    • Association of multiple cut and tissue related issues

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Sectioning Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Sectioning Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Sectioning Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Sectioning Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Sectioning Market

A detailed market share analysis in the Tissue Sectioning Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Sectioning Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Sectioning Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Sectioning Market

A strategic analysis of the Tissue Sectioning Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Sectioning Market, highlighting leading vendors and their innovative profiles. These include Abcam Plc, AGD Biomedicals (P) Ltd., Amos Scientific Pty Ltd, Boeckeler Instruments, Inc., Covance Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, LLS ROWIAK LaserLabSolutions GmbH, MEDITE GmbH, Sakura Finetek Japan, Co., Ltd., SLEE medical GmbH, SM Scientific Instruments Pvt. Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Sectioning Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories & Consumables, Instruments, and Services. The Instruments is further studied across Cryostat, Rotary Microtome, Sliding Microtome, and Ultramicrotome.
  • Based on Technology, market is studied across Automatic, Manual, and Semiautomatic.
  • Based on Application, market is studied across Diagnosis and Research.
  • Based on End-user, market is studied across Clinics, Diagnostic Laboratories, Hospitals, and Research Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Strong demand for histopathology tests
      • 5.1.1.2. Growing prevalence of chronic diseases and cancers
      • 5.1.1.3. Rise in awareness programs undertaken by organizations
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse Reimbursement scenario
    • 5.1.3. Opportunities
      • 5.1.3.1. Growth of personalized therapeutics and diagnostics
      • 5.1.3.2. Rising demand for technologically advanced products
    • 5.1.4. Challenges
      • 5.1.4.1. Association of multiple cut and tissue related issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tissue Sectioning Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories & Consumables
  • 6.3. Instruments
    • 6.3.1. Cryostat
    • 6.3.2. Rotary Microtome
    • 6.3.3. Sliding Microtome
    • 6.3.4. Ultramicrotome
  • 6.4. Services

7. Tissue Sectioning Market, by Technology

  • 7.1. Introduction
  • 7.2. Automatic
  • 7.3. Manual
  • 7.4. Semiautomatic

8. Tissue Sectioning Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnosis
  • 8.3. Research

9. Tissue Sectioning Market, by End-user

  • 9.1. Introduction
  • 9.2. Clinics
  • 9.3. Diagnostic Laboratories
  • 9.4. Hospitals
  • 9.5. Research Centers

10. Americas Tissue Sectioning Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Tissue Sectioning Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Tissue Sectioning Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abcam Plc
  • 2. AGD Biomedicals (P) Ltd.
  • 3. Amos Scientific Pty Ltd
  • 4. Boeckeler Instruments, Inc.
  • 5. Covance Inc.
  • 6. Danaher Corporation
  • 7. Leica Biosystems Nussloch GmbH
  • 8. LLS ROWIAK LaserLabSolutions GmbH
  • 9. MEDITE GmbH
  • 10. Sakura Finetek Japan, Co., Ltd.
  • 11. SLEE medical GmbH
  • 12. SM Scientific Instruments Pvt. Ltd.
  • 13. Thermo Fisher Scientific Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦